Skip to main content

Advertisement

SpringerLink
Log in

Histopathology reporting of prostate needle biopsies. 2005 update

  • Review Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

This report reviews the diagnostic and prognostic importance of the pathologic findings in prostate needle biopsies. The morphological findings of the needle biopsy may be placed into one of the following five categories: prostate cancer, atypical small acinar proliferation, high-grade prostatic intraepithelial neoplasia, inflammation, and benign prostatic tissue. While the prime goal of the biopsy is to diagnose prostatic adenocarcinoma, once carcinoma is detected, further descriptive information regarding the type, amount of cancer, and grade forms the cornerstone for contemporary management of the patient and for assessment of the potential for local cure and the risk for distant metastasis. The information provided in the needle biopsy report regarding the attributes of carcinoma is used depending on the individual patient’s medical condition and preference and on the treating physician’s evaluation to determine whether any form of treatment is indicated and, if so, the type of therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Allsbrook WC Jr, Mangold KA, Johnson MH, Lane RB, Lane CG, Epstein JI (2001) Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists. Hum Pathol 32:74–80

    Article  Google Scholar 

  2. Amin MB, Boccon-Gibod L, Egevad L, Epstein JI, Humphrey PA, Mikuz G, Newling D, Nilsson S, Sakr W, Srigley JR, Wheeler TM, Montironi R (2005) Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens. Scand J Urol Nephrol Suppl 216:20–33

    Article  PubMed  Google Scholar 

  3. Anderson PR, Hanlon AL, Patchefsky A, Al-Saleem T, Hanks GE (1998) Perineural invasion and Gleason 7–10 tumors predict increased failure in prostate cancer patients with pretreatment PSA<10 ng/ml treated with conformal external beam radiation therapy. Int J Radiat Oncol Biol Phys 41:1087–1092

    PubMed  CAS  Google Scholar 

  4. Beach R, Gown AM, De Peralta-Venturina MN, Folpe AL, Yaziji H, Salles PG, Grignon DJ, Fanger GR, Amin MB (2002) P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsis. Am J Surg Pathol 26:1588–1596

    Article  PubMed  CAS  Google Scholar 

  5. Beard CJ, Chen MH, Cote K, Loffredo M, Renshaw AA, Hurwitz M, D’Amico AV (2004) Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer. Int J Radiat Oncol Biol Phys 58:19–24

    Article  PubMed  CAS  Google Scholar 

  6. Bishara T, Ramnani DM, Epstein JI (2004) High-grade prostatic intraepithelial neoplasia on needle biopsy: risk of cancer on repeat biopsy related to number of involved cores and morphologic pattern. Am J Surg Pathol 28:629–633

    PubMed  Google Scholar 

  7. Boccon-Gibod L, van der Kwast TH, Montironi R, Boccon-Gibod L, Bono A (2004) Handling and pathology reporting of prostate biopsies. Eur Urol 46:177–181

    Article  PubMed  Google Scholar 

  8. Bostwick DG (1994) Prostate-specific antigen: current role in diagnostic pathology of prostate cancer. Am J Clin Pathol 102:531–537

    Google Scholar 

  9. Bostwick DG (1995) High-grade prostatic intraepithelial neoplasia: the most likely precursor of prostate cancer. Cancer 75:1823–1836

    Article  Google Scholar 

  10. Bostwick DG, Brawer MK (1987) Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 59:788–794

    Article  PubMed  CAS  Google Scholar 

  11. Bostwick DG, Qian J, Frankel K (1995) The incidence of high-grade prostatic intraepithelial neoplasia in needle biopsies. J Urol 154:1791–1794

    Article  PubMed  CAS  Google Scholar 

  12. Bostwick DG, Wollan P, Adlakha K (1995) Collagenous micronodules in prostate cancer: a specific but infrequent diagnostic finding. Arch Pathol Lab Med 119:444–447

    PubMed  CAS  Google Scholar 

  13. Bostwick DG, Pacelli A, Lopez-Beltran A (1996) Molecular biology of prostatic intraepithelial neoplasia. Prostate 29:117–134

    Article  PubMed  CAS  Google Scholar 

  14. Bostwick DG, Wheeler TM, Blute M (1996) Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology 48:47–57

    Article  PubMed  CAS  Google Scholar 

  15. Bostwick DG, Adolfsson J, Burke HB, Damber J-E, Huland H, Pavone-Macaluso M, Waters DJ (2005) Epidemiology and statistical methods in prediction of patient outcome. Scand J Urol Nephrol Suppl 216:94–110

    Article  PubMed  Google Scholar 

  16. Cohen RJ, Stables S (1998) Intra-prostatic fat. Hum Pathol 29:424–425

    Article  PubMed  CAS  Google Scholar 

  17. Darson MF, Pacelli A, Roche P, Rittenhouse HG, Wolfert RL, Young CY, Klee GG, Tindall DJ, Bostwick DG (1997) Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. Urology 49:857–862

    Article  PubMed  CAS  Google Scholar 

  18. Del Rosario AD, Bui HX, Abdulla M, Ross JS (1993) Sulfur-rich prostatic intraluminal crystalloids: a surgical pathologic and electron probe x-ray microanalytic study. Hum Pathol 24:1159–1167

    Article  PubMed  Google Scholar 

  19. Eble J, Sauter G, Epstein JI, Sesterhenn IA (eds) (2004) WHO classification of tumours. Tumours of the urinary system and male genital organs. (Tumours of the prostate). IARC, Lyon, pp 111–112

    Google Scholar 

  20. Epstein JI (2000) Gleason score 2–4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made. Am J Surg Pathol 24:477–478

    Article  PubMed  CAS  Google Scholar 

  21. Epstein JI (2004) Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy. Mod Pathol 17:307–315

    Article  PubMed  Google Scholar 

  22. Epstein JI, Potter SR (2001) The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies. J Urol 166:402–410

    Article  PubMed  CAS  Google Scholar 

  23. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL, The ISUP Grading Committee (2005) The 2005 International Society of Urological Pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma. Am J Surg Pathol 29:1228–1242

    Article  PubMed  Google Scholar 

  24. Foster CS, Bostwick DG (eds) (1998) Pathology of the prostate. Saunders, Philadelphia, PA, pp 253–281

    Google Scholar 

  25. Freedland SJ, Csathy GS, Dorey F, Aronson WJ (2002) Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. J Urol 167:516–520

    Article  PubMed  Google Scholar 

  26. Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC Jr (2003) The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Cancer 98:2344–2350

    Article  PubMed  Google Scholar 

  27. Freedland SJ, Aronson W, Presti JC Jr, Kane CJ, Terris MK, Elashoff D, Amling CL, The SEARCH Database Study Group (2003) Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database. J Urol 169:2136–2141

    Article  PubMed  Google Scholar 

  28. Gancarczyk KJ, Wu H, McLeod DG, Kane C, Kusuda L, Lance R, Herring J, Foley J, Baldwin D, Bishoff JT, Soderdahl D, Moul JW (2003) Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms. Urology 61:589–595

    Article  PubMed  Google Scholar 

  29. Genega EM, Hutchinson B, Reuter VE, Gaudin PB (2000) Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma. Mod Pathol 13:1186–1191

    Article  PubMed  CAS  Google Scholar 

  30. Gokden N, Roehl KA, Catalona WJ, Humphrey PA (2005) High-grade prostatic intraepithelial neoplasia in needle biopsy as a risk factor for detection of adenocarcinoma. Current level of risk in a screening population. Urology 65:538–542

    Article  PubMed  Google Scholar 

  31. Goldstein NS, Qian J, Bostwick DG (1995) Mucin expression in atypical adenomatous hyperplasia of the prostate. Hum Pathol 26:887–891

    Article  PubMed  CAS  Google Scholar 

  32. Hendrick L, Epstein JI (1989) Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma. Am J Surg Pathol 13:389–396

    Article  Google Scholar 

  33. Holmes GF, Walsh PC, Pound CR, Epstein JI (1999) Excision of the neurovascular bundle at radical prostatectomy in cases with perineural invasion on needle biopsy. Urology 53:752–756

    Article  PubMed  CAS  Google Scholar 

  34. Iczkowski K, MacLennan GT, Bostwick DG (1997) Atypical small acinar proliferation of the prostate suspicious for malignancy in needle biopsies: histologic features and clinical significance in 33 cases. Am J Surg Pathol 21:1489–1495

    Article  PubMed  CAS  Google Scholar 

  35. Irani J, Levillain P, Goujon JM, Bon D, Dore B, Aubert J (1997) Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J Urol 157:1301–1303

    Article  PubMed  CAS  Google Scholar 

  36. Isaacs JT (1997) Molecular markers for prostate cancer metastases: developing diagnostic methods for predicting aggressiveness of prostate cancer. Am J Pathol 150:1511–1521

    PubMed  CAS  Google Scholar 

  37. Ito K, Nakashima J, Mukai M, Asakura H, Ohigashi T, Saito S, Tachibana M, Hata J, Murai M (2003) Prognostic implication of microvascular invasion in biochemical failure in patients treated with radical prostatectomy. Urol Int 70:297–302

    Article  PubMed  Google Scholar 

  38. Jiang Z, Woda BA, Rock KL, Xu Y, Savas L, Khan A, Pihan G, Cai F, Babcook JS, Rathanaswami P, Reed SG, Xu J, Fanger GR (2001) P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol 25:1397–1404

    Article  PubMed  CAS  Google Scholar 

  39. Jiang Z, Wu CL, Woda BA, Dresser K, Xu J, Fanger GR, Yang XJ (2002) P504S/ Alpha-Methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol 26:1169–1174

    Article  PubMed  Google Scholar 

  40. Jones EC, McNeal J, Bruchovsky N, Bruchovsky N, de Jong G (1990) DNA content in prostatic adenocarcinoma: a flow cytometry study of the predictive value of aneuploidy for tumor volume, percentage Gleason grade 4 and 5, and lymph node metastases. Cancer 66:752–757

    Article  PubMed  CAS  Google Scholar 

  41. Kattan MW, Eastham JA, Wheeler TM, Maru N, Scardino PT, Erbersdobler A, Graefen M, Huland H, Koh H, Shariat SF, Slawin KM, Ohori M (2003) Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol 170:1792–1797

    Article  PubMed  Google Scholar 

  42. Kaufmann O, Fietze E, Mengs J, Dietel M (2001) Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 116:823–830

    Article  PubMed  CAS  Google Scholar 

  43. Kestin LL, Goldstein NS, Vicini FA, Martinez AA (2002) Percentage of positive biopsy cores as predictor of clinical outcome in prostate cancer treated with radiotherapy. J Urol 168:1994–1999

    Article  PubMed  CAS  Google Scholar 

  44. Koh H, Kattan MW, Scardino PT, Suyama K, Maru N, Slawin K, Wheeler TM, Ohori M (2003) A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results. J Urol 170:1203–1208

    Article  PubMed  Google Scholar 

  45. Kronz JD, Allan CH, Shaikh AA, Epstein JI (2001) Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy. Am J Surg Pathol 25:1079–1085

    Article  PubMed  CAS  Google Scholar 

  46. Lewis JS Jr, Vollmer RT, Humphrey PA (2002) Carcinoma extent in prostate needle biopsy tissue in the prediction of whole gland tumor volume in a screening population. Am J Clin Pathol 118:442–450

    Article  PubMed  Google Scholar 

  47. Lo J, Kerns BJ, Amling CL, Robertson CN, Layfield LJ (1996) Correlation of DNA ploidy and histologic diagnosis from prostate core-needle biopsies: is DNA ploidy more sensitive than histology for the diagnosis of carcinoma in small specimens? J Surg Oncol 63:41–45

    Article  PubMed  CAS  Google Scholar 

  48. Lowe FC, Trauzzi SJ (1993) Prostatic acid phosphatase in 1993: its limited clinical utility. Urol Clin North Am 20:589–595

    PubMed  CAS  Google Scholar 

  49. Makarov DV, Sanderson H, Partin AW, Epstein JI (2002) Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores? J Urol 167:2440–2442

    Article  PubMed  Google Scholar 

  50. Maru N, Ohori M, Kattan MW, Scardino PT, Wheeler TM (2001) Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens. Hum Pathol 32:828–833

    Article  PubMed  CAS  Google Scholar 

  51. Mendrinos SE, Amin MB, Lim SD, Herrera CM, Srigley JR (2004) Predictive value of pathologic parameters of high-grade prostatic intraepithelial neoplasia (HGPIN) in the initial biopsy for the subsequent detection of prostatic carcinoma (Pca). Mod Pathol 171:168A

    Google Scholar 

  52. Mettlin C, Lee F, Drago J, Murphy GP (1991) The American Cancer Society National Prostate Cancer Detection Project: findings on the detection of early prostate cancer in 2425 men. Cancer 67:2949–2958

    Article  PubMed  CAS  Google Scholar 

  53. Molberg KH, Mikhail A, Vuitch F (1994) Crystalloids in metastatic prostatic adenocarcinoma. Am J Clin Pathol 101:266–268

    PubMed  CAS  Google Scholar 

  54. Montironi R (2001) Prognostic factors in prostate cancer. BMJ 322:378–379

    Article  PubMed  CAS  Google Scholar 

  55. Montironi R, Magi-Galluzzi C, Diamanti L, Taborro R, Scarpelli M, Pisani E (1993) Prostatic intraepithelial neoplasia: qualitative and quantitative analysis of the blood capillary architecture on this tissue sections. Pathol Res Pract 189:542–548

    PubMed  CAS  Google Scholar 

  56. Montironi R, Mazzucchelli R, Scattoni V, Bostwick DG (2002) Pathological findings in TRUS prostatic biopsy — diagnostic, prognostic and therapeutic importance. Eur Urol Suppl 1:60–75

    Article  Google Scholar 

  57. Montironi R, Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Fellegara G, Algaba F (2005) Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology discrepancies. BJU Int 95:1146–1152

    Article  PubMed  Google Scholar 

  58. Montironi R, Mazzucchelli R, Lopez-Beltran A, Algaba F, Scarpelli M, Mikuz G, Boccon-Gibod L (2006) Prostate carcinoma II. Prognostic factors in prostate needle biopsies. BJU Int 97:492

    Article  PubMed  Google Scholar 

  59. Naya Y, Slaton JW, Troncoso P, Okihara K, Babaian RJ (2004) Tumor length and location of cancer on biopsy predict for side specific extraprostatic cancer extension. J Urol 171:1093–1097

    Article  PubMed  Google Scholar 

  60. Oliai BR, Kahane H, Epstein JI (2002) Can basal cells be seen in adenocarcinoma of the prostate? An immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody. Am J Surg Pathol 26:1151–1160

    Article  PubMed  Google Scholar 

  61. Quinn DI, Henshall SM, Brenner PC, Kooner R, Golovsky D, O’Neill GF, Turner JJ, Delprado W, Grygiel JJ, Sutherland RL, Stricker PD (2003) Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion. Cancer 97:1884–1893

    Article  PubMed  Google Scholar 

  62. Roscigno M, Scattoni V, Freschi M, Raber M, Colombo R, Bertini R, Montorsi F, Rigatti P (2004) Monofocal and plurifocal high-grade prostatic intraepithelial neoplasia on extended prostatic biopsies: factors predicting cancer detection on extended repeat biopsy. Urology 63:1105–1110

    Article  PubMed  Google Scholar 

  63. Sakr WA, Grignon DJ, Haas GP, Schomer KL, Heilbrun LK, Cassin BJ, Powell J, Montie JA, Pontes JE, Crissman JD (1995) Epidemiology of high-grade prostatic intraepithelial neoplasia. Pathol Res Pract 191:838–841

    PubMed  CAS  Google Scholar 

  64. Salomao DR, Graham SD, Bostwick DG (1995) Microvascular invasion in prostate cancer correlates with pathologic stage. Arch Pathol Lab Med 119:1050–1054

    PubMed  CAS  Google Scholar 

  65. Scattoni V, Roscigno M, Freschi M, Deho F, Raber M, Briganti A, Fantini G, Nava L, Montorsi F, Rigatti P (2005) Atypical small acinar proliferation (ASAP) on extended prostatic biopsies: predictive factors of cancer detection on repeat biopsies. Arch Ital Urol Androl 77:31–36

    PubMed  Google Scholar 

  66. Schalken JA, Bergh A, Bono A, Foster C, Gospadarowicz M, Isaacs WB, Rubin M, Schroder F, Tribukait B, Tsukamotot T, Wiklund P (2005) Molecular prostate cancer pathology: current issues and achievements. Scand J Urol Nephrol Suppl 216:82–93

    Article  PubMed  Google Scholar 

  67. Schatteman PH, Hoekx L, Wyndaele JJ, Jeuris W, Van Marck E (2000) Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density. Eur Urol 37:404–412

    Article  PubMed  CAS  Google Scholar 

  68. Sebo TJ, Cheville JC, Riehle DL, Lohse CM, Pankratz VS, Myers RP, Blute ML, Zincke H (2001) Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases. Cancer 91:2196–2204

    Article  PubMed  CAS  Google Scholar 

  69. Shah RB, Zhou M, LeBlanc M, Snyder M, Rubin MA (2002) Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol 26:1161–1168

    Article  PubMed  Google Scholar 

  70. Shankey TV, Kallioniemi OP, Koslowski JM, Lieber ML, Mayall BH, Miller G, Smith GJ (1993) Consensus review of the clinical utility of DNA content cytometry in prostate cancer. Cytometry 14:497–500

    Article  PubMed  CAS  Google Scholar 

  71. Shariat SF, Khoddami SM, Saboorian H, Koeneman KS, Sagalowsky AI, Cadeddu JA, McConnell JD, Holmes MN, Roehrborn CG (2004) Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy. J Urol 171:1122–1127

    Article  PubMed  Google Scholar 

  72. Srigley JR, Amin MB, Boccon-Gibod L, Egevad L, Epstein JI, Humphrey PA, Mikuz G, Newling D, Nilsson S, Sakr W, Wheeler TM, Montironi R (2005) Prognostic and predictive factors in prostate cancer: historical perspectives and recent international consensus initiatives. Scand J Urol Nephrol Suppl 216:8–19

    Article  PubMed  Google Scholar 

  73. Takai K, Goellner JR, Katzmann JA et al. (1994) Static image and flow DNA cytometry of prostatic adenocarcinoma: studies of needle biopsy and radical prostatectomy specimens. J Urol Pathol 2:39–48

    Google Scholar 

  74. Thorson P, Vollmer RT, Arcangeli C, Keetch DW, Humphrey PA (1998) Minimal carcinoma in prostate needle biopsy specimens: diagnostic features and radical prostatectomy follow-up. Mod Pathol 11:543–551

    PubMed  CAS  Google Scholar 

  75. Tribukait B (1993) Nuclear deoxyribonucleic acid determination in patients with prostate carcinoma: clinical research and application. Eur Urol 23:64–76

    PubMed  Google Scholar 

  76. Vargas SO, Jiroutek M, Welch WR, Nucci MR, D’Amico AV, Renshaw AA (1999) Perineural invasion in prostate needle biopsy specimens. Correlation with extraprostatic extension at resection. Am J Clin Pathol 111:223–228

    PubMed  CAS  Google Scholar 

  77. Xu J, Stolk JA, Zhang X, Silva SJ, Houghton RL, Matsumura M, Vedvick TS, Leslie KB, Badaro R, Reed SG (2000) Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res 60:1677–1682

    PubMed  CAS  Google Scholar 

  78. Yang XJ, Wu CL, Woda BA, Dresser K, Tretiakova M, Fanger GR, Jiang Z (2002) Expression of Alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol 26:921–925

    Article  PubMed  Google Scholar 

  79. Young RH, Srigley JR, Amin MB, Ulbright TM, Cubilla AL (2000) Tumors of the prostate gland, seminal vesicles, male urethra and penis (Fascicle 28), 3rd edn. AFIP, Washington, DC

    Google Scholar 

  80. Zhou M, Epstein JI (2003) The reporting of prostate cancer on needle biopsy: prognostic and therapeutic implications and the utility of diagnostic markers. Pathology 35:472–479

    Article  PubMed  Google Scholar 

  81. Zhou M, Chinnaiyan AM, Kleer CG, Lucas PC, Rubin MA (2002) Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions. Am J Surg Pathol 26:926–931

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The publication of this paper is in part supported by a grant from the Italian Ministry of University and Scientific Research (RM) (MIUR 2003).

Author information

Authors and Affiliations

  1. Institute of Pathological Anatomy and Histopathology, Polytechnic University of the Marche Region (Ancona), School of Medicine, United Hospitals, Via Conca 71, 60020, Torrette, Ancona, Italy

    Rodolfo Montironi & Roberta Mazzucchelli

  2. Urology Service and Renal Transplantation Unit, Autonomous University of Madrid, Madrid, Spain

    Remigio Vela Navarrete

  3. Department of Pathology, Reina Sofia University Hospital and Cordoba University Medical School, Cordoba, Spain

    Antonio Lopez-Beltran

  4. Department of Pathology, University of Innsbruck School of Medicine, Innsbruck, Austria

    Gregor Mikuz

  5. Department of Urology, Ospedale di Circolo, Varese, Italy

    Aldo V. Bono

Authors
  1. Rodolfo Montironi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Remigio Vela Navarrete
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonio Lopez-Beltran
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Roberta Mazzucchelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gregor Mikuz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Aldo V. Bono
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rodolfo Montironi.

Additional information

Issues on the pathology reporting of prostate needle biopsies have been dealt with in recent consensus conferences organized under the auspices of the Uropathology Working Group (European Society of Pathology), European Society of Uropathology (a full section office member of the European Association of Urology) (Florence, Italy, June 2003, and Palermo, Sicily, June 2005), World Health Organization (Lyon, France, December 2002, and Stockholm, Sweden, September 2004), and International Society of Urologic Pathology (San Antonio, TX, USA, March 2005). The authors of this review have been involved in these conferences.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Montironi, R., Vela Navarrete, R., Lopez-Beltran, A. et al. Histopathology reporting of prostate needle biopsies. 2005 update. Virchows Arch 449, 1–13 (2006). https://doi.org/10.1007/s00428-006-0190-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-006-0190-9

Keywords

Search

Navigation